Translating blood-based biomarkers into Alzheimer’s disease clinical practice: screening, diagnosis, and longitudinal monitoring
A review of recent advances in BBMs through the ATN-I framework explores how integrating BBMs with traditional cerebrospinal fluid and neuroimaging tests may support symptom-driven clinical triage, probability refinement, and early evaluation in selected individuals, improving clinical workflow efficiency and accessibi...